We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$188M
AUM Growth
+$30.7M
Cap. Flow
+$18.4M
Cap. Flow %
9.8%
Top 10 Hldgs %
6.1%
Holding
495
New
69
Increased
189
Reduced
162
Closed
73

Top Buys

Rank Stock Value
1
TCPC icon
BlackRock TCP Capital
TCPC
+$1.06M
2
HST icon
Host Hotels & Resorts
HST
+$965K
3
PLTR icon
Palantir
PLTR
+$932K
4
PSA icon
Public Storage
PSA
+$920K
5
DFS
Discover Financial Services
DFS
+$865K

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$962K
2
PLD icon
Prologis
PLD
+$773K
3
BKNG icon
Booking.com
BKNG
+$734K
4
ETN icon
Eaton
ETN
+$720K
5
TEL icon
TE Connectivity
TEL
+$708K

Sector Composition

Rank Sector Weight
1 Healthcare 21.52%
2 Financials 20.16%
3 Technology 16.46%
4 Industrials 8.76%
5 Energy 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGT icon
176
BlackRock Floating Rate Income Trust
BGT
$322M
$526K 0.28%
40,538
+8,730
+27% +$110K
TSLX icon
177
Sixth Street Specialty
TSLX
$1.68B
$523K 0.28%
24,399
+5,856
+32% +$126K
SRPT icon
178
Sarepta Therapeutics
SRPT
$1.63B
$522K 0.28%
4,031
+580
+17% +$71K
HTGC icon
179
Hercules Capital
HTGC
$3.04B
$513K 0.27%
27,782
-735
-3% -$13K
ASND icon
180
Ascendis Pharma A/S
ASND
$16.7B
$480K 0.25%
3,172
+456
+17% +$65.1K
AGIO icon
181
Agios Pharmaceuticals
AGIO
$2.14B
$479K 0.25%
16,395
+2,359
+17% +$63.2K
MRNA icon
182
Moderna
MRNA
$22.1B
$473K 0.25%
4,437
+638
+17% +$64.3K
BXSL icon
183
Blackstone Secured Lending
BXSL
$5.43B
$465K 0.25%
14,938
+5,048
+51% +$148K
MAIN icon
184
Main Street Capital
MAIN
$5.14B
$463K 0.25%
9,784
+1,730
+21% +$78.2K
DCF
185
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$452K 0.24%
52,445
+9,772
+23% +$82.4K
KNSA icon
186
Kiniksa Pharmaceuticals
KNSA
$6.11B
$441K 0.23%
22,347
+3,215
+17% +$62.8K
NBIX icon
187
Neurocrine Biosciences
NBIX
$18.4B
$433K 0.23%
3,140
+452
+17% +$61.7K
BPMC
188
DELISTED
Blueprint Medicines
BPMC
$431K 0.23%
4,546
+654
+17% +$56.1K
APLS
189
DELISTED
Apellis Pharmaceuticals
APLS
$429K 0.23%
7,302
+1,051
+17% +$67K
AXSM icon
190
Axsome Therapeutics
AXSM
$12.1B
$415K 0.22%
5,200
+748
+17% +$62.8K
CRSP icon
191
CRISPR Therapeutics
CRSP
$4.68B
$413K 0.22%
6,054
+871
+17% +$62.4K
LGND icon
192
Ligand Pharmaceuticals
LGND
$5.94B
$411K 0.22%
5,628
+810
+17% +$59.7K
ITCI
193
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$404K 0.21%
5,833
+839
+17% +$57.7K
PTCT icon
194
PTC Therapeutics
PTCT
$6.25B
$402K 0.21%
13,805
+1,986
+17% +$55.6K
HALO icon
195
Halozyme
HALO
$9.9B
$393K 0.21%
9,659
+1,390
+17% +$52.1K
AMGN icon
196
Amgen
AMGN
$212B
$393K 0.21%
1,381
+200
+17% +$58.5K
EXEL icon
197
Exelixis
EXEL
$14.2B
$388K 0.21%
16,346
+2,352
+17% +$52.3K
IMCR icon
198
Immunocore
IMCR
$1.7B
$388K 0.21%
5,962
+858
+17% +$58.9K
RARE icon
199
Ultragenyx Pharmaceutical
RARE
$2.56B
$387K 0.21%
8,299
+1,194
+17% +$56.3K
RYTM icon
200
Rhythm Pharmaceuticals
RYTM
$7.41B
$385K 0.2%
8,874
+1,277
+17% +$55.9K
6 7
8
9 10

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Virtus ETF Advisers held 495 positions worth $188M, up 19% from $158M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $18.4M of net new capital in Q1 2024, opening 69 new positions and adding to 189 existing holdings. Its largest new stake was Host Hotels & Resorts: 47,997 shares worth $993K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was ConocoPhillips, an estimated $569K trimmed.

  • Virtus ETF Advisers's largest Q1 2024 buy was Host Hotels & Resorts: 47,997 shares worth $993K.
  • Virtus ETF Advisers added most to BlackRock TCP Capital in Q1 2024, an estimated $1.06M increase.
  • Virtus ETF Advisers's biggest Q1 2024 reduction was ConocoPhillips, cutting an estimated $569K.
  • Virtus ETF Advisers fully exited Burlington in Q1 2024, selling an estimated $962K.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $188M portfolio in Q1 2024.
  • Virtus ETF Advisers opened 69 new positions and closed 73 in Q1 2024.
  • Virtus ETF Advisers's portfolio value rose 19% quarter-over-quarter to $188M.

Based on Virtus ETF Advisers's 13F filing for Q1 2024, filed 15 May 2024.